Immunohistochemistry revealed positivity for signal transducer and activator of transcription 6 (STAT6) and negativity for cluster of differentiation 34 (CD34), confirming the diagnosis of SFT. The gene discussed is STAT6; the disease is solitary fibrous tumor.